利用者:LeanderNeedham316

Graviola is a tiny, upright evergreen tree growing 5 to 6 meters in height by having big dark green and glossy leaves. It is indigenous to many of the warmest tropical areas in South and North The united state consisting of the Amazon. It produces a big heart-shaped nutritious fruit that is 6-9", yellow green in color, with white flesh. The fruit is offered in local markets in the tropics where it is called Guanabana or Brazilian Cherimoya and is impressive for making beverages and sherbets and, though slightly sour-acid, can easily be eaten out-of-hand.

All parts of the Graviola tree as listed on www.graviolacancers.com are used in alternative medicine in the tropics including the bark, leaves, roots, fruit and fruit-seeds. Different properties and uses are credited to the different parts of the tree. Typically the fruit and fruit juice is taken for worms and parasites, to cool fevers, to increase mother's milk after childbirth (lactagogue), and as an astringent for diarrhea and dysentery. The crushed seeds are used as a vermifuge and anthelmintic against internal and external parasites and worms. The bark, leaves and roots are considered sedative, antispasmodic, hypotensive and nervine and a tea is made for several disorders for those purposes.

Several bioactive compounds and phytochemicals have actually been discovered in Graviola as experts have actually been studying its properties because the 1940's. Its many utilizations in alternative medicine has been validated by this clinical study. The earliest studies were between 1941 and 1962. Numerous researches by different analysts indicated that the bark and also the leaves had hypotensive, antispasmodic, vasodilator, easy muscle relaxant and cardiodepressant tasks in animals. Researchers re-verified Graviola leaf's hypotensive properties in rats again in 1991. Many studies over the years have actually shown that leaf, bark, root, stem and seed extractions of Graviola are antibacterial in vitro against various pathogens and that the bark has antifungal properties. Graviola seeds showed active antiparasitic properties in a 1991 research, and a leaf extract showed to be active against malaria in 2 other studies in 1990 and 1993. The leaves, root, and seeds of Graviola indicated insecticidal properties with the seed demonstrating solid insecticidal activity in an early 1940 research. In a new 1997 medical research, novel alkaloids were discovered in Graviola fruit by having anti-depressive consequences in animals.

In an 1976 plant filtering program by the National Cancer Institute, the leaves and stem of Graviola showed active cytotoxicity against cancer cells and analysts have been following up on this analysis ever before because. Much of the analysis on Graviola concentrates on a novel set of phytochemicals called annonaceous acetogenins. The potent antitumor, pesticidal and/or insect antifeedant properties of these annonaceous acetogenins have actually been reported and patented. Graviola creates these natural compounds in leaf, bark and twig tissues, and they have actually be chronicled to possess both highly anti-tumor and pesticidal properties.

3 different analysis groups have actually isolated novel compounds in the seeds and leaves of Graviola which have actually demonstrated significant anti-tumorous, anticancerous and selective toxicity against several kinds of cancer cells, publishing 8 clinical studies on their locatings. One study showed that an acetogenin in Graviola was selectively cytotoxic to colon adenocarcinoma cells in which it was 10,000 times the potency of adriamycin (a chemotherapy medication). Cancer study is ongoing on Graviola, and 4 new researches have actually been released in 1998 which further narrow down the certain phytochemicals which are showing the strongest anticancerous and antiviral properties.

Another write-up in the Skaggs Scientific Report 1997-1998 states, "Annonaceous acetogenins, especially those with adjacent bis-tetrahydrofuran (THF) rings, have exceptional cytotoxic, antitumor, antimalarial, immunosuppressive, pesticidal, and antifeedant activities. Numerous of these fatty acid derivatives have comparable carbon skeletons; their striking choice originates normally from the relative and downright settings of their different stereogenic oxygen operations."

Purdue College has carried out a large amount of analysis on annonaceaous acetogenins, a lot of which has actually been funded by The National Cancer Institute and/or the National Institute of Health. In one of their evaluations titled The past few Advances in Annonaceous Acetogenins, they state: "Annonaceous acetogenins are waxy substances including C32 or C34 long chain fatty acids which have been mixed with a 2-propanol unit at C-2 to form a lactone. They are just identified in many genera of the plant family members, Annonaceae. Their assorted bioactivities as antitumor, immunosuppressive, pesticidal, antiprotozoal, antifeedant, anthelmintic, and antimicrobial representatives, have actually enticed many interest worldwide. Just recently, we reported that the Annonaceous acetogenins can selectively hinder the development of cancerous cells as well as inhibit the development of adriamycin resistant tumor cells. As even more acetogenins have been isolated and additional cytotoxicity assays have been performed, we have seen that, although many of acetogenins have high potencies among many sound human tumor cell lines, a couple of the derivatives within the different structural types and some positional isomers showed remarkable selectivity's amongst certain cell lines, e.g., against prostate cancer (PC-3). We now understand the main methods of activity for the acetogenins. They are potent obviations of NADH: ubiquinone oxidoreductase, which is in a necessary enzyme in complex I resulting in oxidative phosphorylation in mitochondria. A recent report showed that they act straight at the ubiquinone-catalytic site (s) within complex I and in microbial glucose dehydrogenase. They also inhibit the ubiquinone-linked NADH oxidase that is peculiar to the plasma membranes of cancerous cells."

In 1997, Purdue University published data with promising news that several of the annona acetogenins "not only are effective in eradicating tumors that have actually shown resistant to anti-cancer agents, but even appear to have a special affinity for such resistant cells." In numerous interviews after this data was advertised, Purdue pharmacologist Dr. Jerry McLaughlin, the lead researcher in many of Purdue's researches on the Annona chemicals, says cancer cells that survive chemotherapy might develop resistance to the agent originally made use of against them as well as to additional, even unrelated, medicines. "The term multi-drug resistance (MDR) has been put on this anomaly," McLaughlin says. He clarifies that such resistance develops in a tiny percentage of cancer cells when they develop a "P-glycoprotein mediated pump" capable of pushing anti-cancer agents away from the cell prior to they can kill it. Typical cells seldom establish such a pump.

In the June issue of Cancer Letters, the Purdue researchers reported that the annona acetogenin, bullatacin, preferentially killed multi-drug resistant cancer cells due to the fact that it blocked development of adenosine triphosphate, ATP, the chief energy-carrying compound in the body. "A multi-drug resistant cell requires a tremendous quantity of power to run the pump and extrude points away from the cell," McLaughlin says. "By hindering ATP processing, we're essentially pulling the plug on its power source." But the about the outcome on ATP in usual cells? "Typical cells and standard cancer cells might be able to minimize the consequence of this compound since they don't require huge quantities of energy wanted by the pump-running cells," the Purdue analyst says. "The resistant cell is using its extra power for this pump as well as to expand, so it is really taxed for power. When we mess with the power supply, it eradicates the cell."

In the June issue of the Journal of Medicinal Chemistry, McLaughlin and his co-workers described a research of 14 Annona compounds that seem to be potent ATP blockers. "This study informs us exactly how to optimize this activity, so we have a rather great strategy what compounds we will like to try in animals by having multi-drug resistant tumors," he points out.

While current study on Graviola has actually concentrated on its cancer-fighting result it is intriguing to note that medication men in South The united state have actually utilized it for centuries to treat an unbelievable amount of conditions.

http://markets.chron.com/chron/news/read?GUID=21132884